Oppenheimer Lowers Amrize (NYSE:AMRZ) Price Target to $65.00

Amrize (NYSE:AMRZ) had its price objective lowered by stock analysts at Oppenheimer from $68.00 to $65.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Oppenheimer’s target price suggests a potential upside of 30.90% from the company’s previous close.

Several other brokerages have also weighed in on AMRZ. Morgan Stanley set a $63.00 price objective on Amrize and gave the company an “overweight” rating in a report on Monday, June 22nd. Citigroup decreased their target price on Amrize from $76.00 to $66.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Weiss Ratings downgraded Amrize from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, July 13th. Royal Bank Of Canada dropped their price target on Amrize from $61.00 to $60.00 and set a “sector perform” rating on the stock in a research report on Friday, May 1st. Finally, Vertical Research upgraded Amrize from a “hold” rating to a “buy” rating and set a $70.00 price objective on the stock in a research note on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $62.79.

Amrize Price Performance

Shares of AMRZ stock opened at $49.66 on Tuesday. The firm has a fifty day moving average of $52.14 and a two-hundred day moving average of $55.20. The firm has a market cap of $27.46 billion and a P/E ratio of 23.76. Amrize has a 1-year low of $44.12 and a 1-year high of $65.94. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.40 and a quick ratio of 0.89.

Amrize (NYSE:AMRZ) last issued its earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.84%. The company had revenue of $2.18 billion during the quarter. The company’s revenue for the quarter was up 4.7% on a year-over-year basis. As a group, research analysts anticipate that Amrize will post 2.74 earnings per share for the current fiscal year.

Insider Buying and Selling at Amrize

In related news, CTO Roald Brouwer bought 1,500 shares of the firm’s stock in a transaction on Thursday, May 21st. The stock was bought at an average cost of $49.84 per share, for a total transaction of $74,760.00. Following the completion of the purchase, the chief technology officer directly owned 19,757 shares in the company, valued at approximately $984,688.88. The trade was a 8.22% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Mario Gross bought 2,800 shares of the stock in a transaction dated Tuesday, May 19th. The shares were bought at an average cost of $49.17 per share, with a total value of $137,676.00. Following the completion of the acquisition, the insider directly owned 33,747 shares of the company’s stock, valued at approximately $1,659,339.99. The trade was a 9.05% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last three months, insiders bought 54,920 shares of company stock worth $2,717,429. Insiders own 0.54% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in AMRZ. HF Advisory Group LLC increased its position in Amrize by 323.3% in the second quarter. HF Advisory Group LLC now owns 21,325 shares of the company’s stock worth $1,137,000 after buying an additional 16,287 shares during the period. Norman Fields Gottscho Capital Management LLC boosted its holdings in shares of Amrize by 4.3% during the second quarter. Norman Fields Gottscho Capital Management LLC now owns 11,515 shares of the company’s stock valued at $614,000 after acquiring an additional 475 shares during the period. DMKC Advisory Services LLC grew its position in shares of Amrize by 11.9% during the second quarter. DMKC Advisory Services LLC now owns 67,832 shares of the company’s stock worth $3,615,000 after acquiring an additional 7,223 shares during the last quarter. Grove Bank & Trust grew its position in shares of Amrize by 5.6% during the second quarter. Grove Bank & Trust now owns 17,124 shares of the company’s stock worth $913,000 after acquiring an additional 906 shares during the last quarter. Finally, Glenmede Trust Co. NA acquired a new stake in shares of Amrize in the 1st quarter worth about $270,000.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.